GlobalData, the industry analysis specialist, has released its new report, “Periodontal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Periodontal Disease Therapeutics market. The report identifies the key trends shaping and driving the global Periodontal Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Periodontal Disease Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Periodontal Disease Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Periodontal Disease Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Periodontal Disease Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Periodontal Disease Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Periodontal Disease Therapeutics market
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Periodontal Disease Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Periodontal Disease Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Periodontal Disease Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Periodontal Disease Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Periodontal Disease Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Periodontal Disease Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Periodontal Disease Therapeutics market landscape? – Identify, understand and capitalize.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Periodontal Disease Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Periodontal Disease Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Periodontal Disease Therapeutics market landscape? – Identify, understand and capitalize.
Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Periodontal Disease Therapeutics - Introduction 7
2.1 Disease Overview 7
2.2 Etiology and Pathogenesis 8
2.3 Signs and Symptoms 11
2.4 Epidemiology 12
2.5 Socio-econiomic Status and Quality of Life 13
2.6 Diagnosis 14
2.7 Treatment and Management Pattern 16
2.8 Referral Pathway 20
2.9 GlobalData Pipeline Report Guidance 21
3 Periodontal Disease Therapeutics - Market Characterization 22
3.1 Periodontal Disease Therapeutics Market Size (2005 - 2010) - Global 22
3.2 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Global 23
3.3 Periodontal Disease Therapeutics Market Size (2005–2010) – The US 24
3.4 Periodontal Disease Therapeutics Market Forecast (2010–2018) – The US 25
3.5 Periodontal Disease Therapeutics Market Size (2005–2010) – The UK 26
3.6 Periodontal Disease Therapeutics Market Forecast (2010–2018) – The UK 27
3.7 Periodontal Disease Therapeutics Market Size (2005–2010) – France 28
3.8 Periodontal Disease Therapeutics Market Forecast (2010–2018) – France 29
3.9 Periodontal Disease Therapeutics Market Size (2005–2010) – Germany 30
3.10 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Germany 31
3.11 Periodontal Disease Therapeutics Market Size (2005–2010) – Italy 32
3.12 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Italy 33
3.13 Periodontal Disease Therapeutics Market Size (2005–2010) – Spain 34
3.14 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Spain 35
3.15 Periodontal Disease Therapeutics Market Size (2005–2010) – Japan 36
3.16 Periodontal Disease Therapeutics Market Size (2010–2018) – Japan 37
3.17 Drivers and Barriers for the Periodontal Disease Therapeutics Market 38
3.17.1 Drivers for Periodontal Disease Market 38
3.17.2 Barriers for Periodontal Disease Market 38
3.18 Opportunity and Unmet Need Analysis 39
3.19 Key Takeaway 39
4 Periodontal Disease Therapeutics - Competitive Assessment 41
4.1 Overview 41
4.2 Strategic Competitor Assessment 41
4.3 Product Profiles for the Major Marketed Products in the Periodontal Disease Therapeutics Market 42
4.3.1 Periostat (doxycycline hyclate) 42
4.3.2 Periochip (chlorhexidine gluconate) 43
4.3.3 Arestin (minocycline hydrochloride microspheres) 44
4.3.4 Atridox (doxycycline hyclate 10%) 45
4.4 Key Takeaway 46
5 Periodontal Disease Therapeutics Market - Pipeline Assessment 47
5.1 Overview 47
5.2 Strategic Pipeline Assessment 47
5.3 Periodontal Disease Therapeutics Pipeline – Pipeline by Phases of Development 47
5.3.1 Periodontal Disease Therapeutics – Regulatory Filed Products 48
5.3.2 Periodontal Disease Therapeutics – Phase III Pipeline 48
5.3.3 Periodontal Disease Therapeutics – Phase II Pipeline 48
5.3.4 Periodontal Disease Therapeutics – Discovery and Pre-Clinical Pipeline 48
5.3.5 Technology Trends Analytic Framework 49
5.4 Periodontal Disease Therapeutics Market – Pipeline by Mechanism of Action 51
5.5 Periodontal Disease Therapeutics – Promising Drugs under Clinical Development 52
5.6 Molecule Profile for Promising Drugs under Clinical Development 52
5.6.1 KCB-1D (trafermin, bFGF: Basic fibroblast growth factor) 52
5.7 Key Takeaway 53
6 Periodontal Disease Therapeutics - Clinical Trials Mapping 54
6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 54
6.2 Clinical Trials by Phase 55
6.3 Clinical Trials by Trial Status 56
6.4 Clinical Trials by Sponsors 57
6.5 Top Companies Participating in Periodontal Disease Therapeutics Clinical Trials 59
7 Periodontal Disease Therapeutics - Strategic Assessment 60
7.1 Key Events Impacting the Future Market 60
7.2 Periodontal Disease Therapeutics: Implications for Future Market Competition 61
8 Periodontal Disease Therapeutics - Future Players 62
8.1 Introduction 62
8.2 Company Profiles 63
8.2.1 Kaken Pharmaceutical 63
8.2.2 Scil Technology 64
8.2.3 Fibrocell 65
8.2.4 Other Companies in the Periodontal Disease Therapeutics Market 67
9 Periodontal Disease Therapeutics - Licensing and Partnership Deals 68
10 Periodontal Disease Therapeutics - Appendix 69
10.1 Market Definitions 69
10.2 Abbreviations 69
10.3 Research Methodology 69
10.3.1 Coverage 70
10.3.2 Secondary Research 70
10.3.3 Forecasting 70
10.3.4 Primary Research 72
10.3.5 Expert Panel Validation 72
10.4 Contact Us 72
10.5 Disclaimer 72
10.6 Bibliography 73
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Periodontal Disease Therapeutics - Introduction 7
2.1 Disease Overview 7
2.2 Etiology and Pathogenesis 8
2.3 Signs and Symptoms 11
2.4 Epidemiology 12
2.5 Socio-econiomic Status and Quality of Life 13
2.6 Diagnosis 14
2.7 Treatment and Management Pattern 16
2.8 Referral Pathway 20
2.9 GlobalData Pipeline Report Guidance 21
3 Periodontal Disease Therapeutics - Market Characterization 22
3.1 Periodontal Disease Therapeutics Market Size (2005 - 2010) - Global 22
3.2 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Global 23
3.3 Periodontal Disease Therapeutics Market Size (2005–2010) – The US 24
3.4 Periodontal Disease Therapeutics Market Forecast (2010–2018) – The US 25
3.5 Periodontal Disease Therapeutics Market Size (2005–2010) – The UK 26
3.6 Periodontal Disease Therapeutics Market Forecast (2010–2018) – The UK 27
3.7 Periodontal Disease Therapeutics Market Size (2005–2010) – France 28
3.8 Periodontal Disease Therapeutics Market Forecast (2010–2018) – France 29
3.9 Periodontal Disease Therapeutics Market Size (2005–2010) – Germany 30
3.10 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Germany 31
3.11 Periodontal Disease Therapeutics Market Size (2005–2010) – Italy 32
3.12 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Italy 33
3.13 Periodontal Disease Therapeutics Market Size (2005–2010) – Spain 34
3.14 Periodontal Disease Therapeutics Market Forecast (2010–2018) – Spain 35
3.15 Periodontal Disease Therapeutics Market Size (2005–2010) – Japan 36
3.16 Periodontal Disease Therapeutics Market Size (2010–2018) – Japan 37
3.17 Drivers and Barriers for the Periodontal Disease Therapeutics Market 38
3.17.1 Drivers for Periodontal Disease Market 38
3.17.2 Barriers for Periodontal Disease Market 38
3.18 Opportunity and Unmet Need Analysis 39
3.19 Key Takeaway 39
4 Periodontal Disease Therapeutics - Competitive Assessment 41
4.1 Overview 41
4.2 Strategic Competitor Assessment 41
4.3 Product Profiles for the Major Marketed Products in the Periodontal Disease Therapeutics Market 42
4.3.1 Periostat (doxycycline hyclate) 42
4.3.2 Periochip (chlorhexidine gluconate) 43
4.3.3 Arestin (minocycline hydrochloride microspheres) 44
4.3.4 Atridox (doxycycline hyclate 10%) 45
4.4 Key Takeaway 46
5 Periodontal Disease Therapeutics Market - Pipeline Assessment 47
5.1 Overview 47
5.2 Strategic Pipeline Assessment 47
5.3 Periodontal Disease Therapeutics Pipeline – Pipeline by Phases of Development 47
5.3.1 Periodontal Disease Therapeutics – Regulatory Filed Products 48
5.3.2 Periodontal Disease Therapeutics – Phase III Pipeline 48
5.3.3 Periodontal Disease Therapeutics – Phase II Pipeline 48
5.3.4 Periodontal Disease Therapeutics – Discovery and Pre-Clinical Pipeline 48
5.3.5 Technology Trends Analytic Framework 49
5.4 Periodontal Disease Therapeutics Market – Pipeline by Mechanism of Action 51
5.5 Periodontal Disease Therapeutics – Promising Drugs under Clinical Development 52
5.6 Molecule Profile for Promising Drugs under Clinical Development 52
5.6.1 KCB-1D (trafermin, bFGF: Basic fibroblast growth factor) 52
5.7 Key Takeaway 53
6 Periodontal Disease Therapeutics - Clinical Trials Mapping 54
6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 54
6.2 Clinical Trials by Phase 55
6.3 Clinical Trials by Trial Status 56
6.4 Clinical Trials by Sponsors 57
6.5 Top Companies Participating in Periodontal Disease Therapeutics Clinical Trials 59
7 Periodontal Disease Therapeutics - Strategic Assessment 60
7.1 Key Events Impacting the Future Market 60
7.2 Periodontal Disease Therapeutics: Implications for Future Market Competition 61
8 Periodontal Disease Therapeutics - Future Players 62
8.1 Introduction 62
8.2 Company Profiles 63
8.2.1 Kaken Pharmaceutical 63
8.2.2 Scil Technology 64
8.2.3 Fibrocell 65
8.2.4 Other Companies in the Periodontal Disease Therapeutics Market 67
9 Periodontal Disease Therapeutics - Licensing and Partnership Deals 68
10 Periodontal Disease Therapeutics - Appendix 69
10.1 Market Definitions 69
10.2 Abbreviations 69
10.3 Research Methodology 69
10.3.1 Coverage 70
10.3.2 Secondary Research 70
10.3.3 Forecasting 70
10.3.4 Primary Research 72
10.3.5 Expert Panel Validation 72
10.4 Contact Us 72
10.5 Disclaimer 72
10.6 Bibliography 73
Related Market Research Reports:
About Us:
ReportsnReports.com is an online market research library of 135,000+ reports and in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Visit http://www.reportsnreports.com/ for more details.
Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/
Connect with us on:
Twitter @ http://www.twitter.com/marketsreports
No comments:
Post a Comment